We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hormel Foods (HRL) to Post Q2 Earnings: What's in the Cards?
Read MoreHide Full Article
Hormel Foods Corporation (HRL - Free Report) is slated to report second-quarter fiscal 2019 results on May 23, before market opens. The company has outperformed the Zacks Consensus Estimate in three of the trailing four quarters with an average beat of 3.4%. Let’s see what’s in store for this renowned meat products company this time.
Which Way Are Estimates Heading?
The Zacks Consensus Estimate for the quarter under review is pegged at 45 cents reflecting growth of 2.3% from 44 cents reported in the year-ago quarter. Notably, the Zacks Consensus Estimate has gone down by a penny in the past 30 days.
The Zacks Consensus Estimate for revenues is $2,368 million, up 1.6% from $2,331 million reported in the year-ago quarter. We note that total revenues of the company increased 1.2% in the last-reported quarter.
Soft turkey market conditions have kept Hormel Foods pressurized for quite some time now. Though the company is focused on reviving the turkey supply chain via increased investment in Jennie-O brand, management anticipates soft sales performance in the Jennie-O Turkey store in the to-be-reported quarter.
Additionally, the company expects elevated raw material costs in the second quarter owing to harsh weather conditions. Continued volatility owing to trade uncertainty associated with African swine fever and tariffs may aggravate input costs. This is likely to hurt the company’s profitability to some extent.
However, Hormel Foods’ food service business is performing well both domestically and in China. The company is on track with its innovation efforts and expects to expedite the process of delivering more unique products to the market. These apart, it expects certain categories such as refrigerated foods, grocery products, deli food service and its China business to remain sturdy, which bodes well for the second quarter.
Zacks Model
Our proven model doesn’t show that Hormel Foods is likely to beat bottom-line estimates this quarter. For this to happen, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Here are some companies you may want to consider as our model shows that they have the right combination of elements to beat estimates.
Kimberly-Clark Corp. (KMB - Free Report) has an Earnings ESP of +0.04% and a Zacks Rank #2.
Target Corp. (TGT - Free Report) has an Earnings ESP of +0.70% and a Zacks Rank #2.
Costco Wholesale Corp. (COST - Free Report) has an Earnings ESP of +1.65% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Hormel Foods (HRL) to Post Q2 Earnings: What's in the Cards?
Hormel Foods Corporation (HRL - Free Report) is slated to report second-quarter fiscal 2019 results on May 23, before market opens. The company has outperformed the Zacks Consensus Estimate in three of the trailing four quarters with an average beat of 3.4%. Let’s see what’s in store for this renowned meat products company this time.
Which Way Are Estimates Heading?
The Zacks Consensus Estimate for the quarter under review is pegged at 45 cents reflecting growth of 2.3% from 44 cents reported in the year-ago quarter. Notably, the Zacks Consensus Estimate has gone down by a penny in the past 30 days.
The Zacks Consensus Estimate for revenues is $2,368 million, up 1.6% from $2,331 million reported in the year-ago quarter. We note that total revenues of the company increased 1.2% in the last-reported quarter.
Hormel Foods Corporation Price and EPS Surprise
Hormel Foods Corporation price-eps-surprise | Hormel Foods Corporation Quote
Factors Setting the Tone
Soft turkey market conditions have kept Hormel Foods pressurized for quite some time now. Though the company is focused on reviving the turkey supply chain via increased investment in Jennie-O brand, management anticipates soft sales performance in the Jennie-O Turkey store in the to-be-reported quarter.
Additionally, the company expects elevated raw material costs in the second quarter owing to harsh weather conditions. Continued volatility owing to trade uncertainty associated with African swine fever and tariffs may aggravate input costs. This is likely to hurt the company’s profitability to some extent.
However, Hormel Foods’ food service business is performing well both domestically and in China. The company is on track with its innovation efforts and expects to expedite the process of delivering more unique products to the market. These apart, it expects certain categories such as refrigerated foods, grocery products, deli food service and its China business to remain sturdy, which bodes well for the second quarter.
Zacks Model
Our proven model doesn’t show that Hormel Foods is likely to beat bottom-line estimates this quarter. For this to happen, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Hormel Foods’ carries a Zacks Rank #4 (Sell) and an Earnings ESP of -4.44%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks Poised to Beat Earnings Estimates
Here are some companies you may want to consider as our model shows that they have the right combination of elements to beat estimates.
Kimberly-Clark Corp. (KMB - Free Report) has an Earnings ESP of +0.04% and a Zacks Rank #2.
Target Corp. (TGT - Free Report) has an Earnings ESP of +0.70% and a Zacks Rank #2.
Costco Wholesale Corp. (COST - Free Report) has an Earnings ESP of +1.65% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>